 LEIDEN, Netherlands CAMBRIDGE, Mass., Feb. 07, 2022 GLOBE NEWSWIRE -- ProQR Therapeutics N.V. Nasdaq: PRQR the Company, a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present at the upcoming virtual SVB Leerink 11th Annual Global Healthcare Conference. The presentation will be webcast live on February 17, 2022 from 1:40 2:05pm EST. 